Colossal Now

In October 2024, the company launched the Colossal Foundation , a non-profit dedicated to applying these technologies to today's endangered species. They are currently working on a vaccine for a deadly elephant virus (EEHV) and biobanking the "top 100" most imperiled species to ensure their genetic survival.

Colossal is currently working on several high-profile species: Colossal

: Developing hardware to grow embryos outside a living host. In October 2024, the company launched the Colossal

Colossal aims to restore ecological balance by reintroducing "keystone" species to their original habitats. By reviving these animals, they hope to slow climate change—for example, by having woolly mammoths restore the Arctic grasslands to prevent permafrost melt. Colossal aims to restore ecological balance by reintroducing

: Working with the Mauritian Wildlife Foundation, they plan to return a proxy of the dodo to Mauritius within five to seven years.